Digestive remedies in Saudi Arabia has shown a strong performance in 2026, with retail value sales expected to reach SAR815 million with growth of 8% in current terms, notably exceeding inflation at 2% and outpacing broader economic expansion, underscoring the attractiveness of this space compared to regional patterns. The upward trajectory is reinforced by population growth, high consumer expenditure, and persistent changes in dietary behaviour, particularly the surge in restaurant and convenience food consumption, as well as increased use of GLP-1 therapies such as Ozempic and Mounjaro which are linked to gastrointestinal side-effects. Brands that succeed are those investing in both traditional symptom management, as illustrated by esomeprazole launches for heartburn and reflux, and preventive digestive health through probiotics and fibre-based products, while also leveraging trusted pharmacy distribution and digital innovation in e-commerce and quick commerce channels. With the environment becoming less concentrated as local and regional companies gain share, building strong local manufacturing capabilities, deepening professional relationships, and adapting portfolios to address both acute and preventive needs will be critical for sustained relevance and competitive advantage.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Digestive Remedies industry in Saudi Arabia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Digestive Remedies industry in Saudi Arabia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Digestive Remedies in Saudi Arabia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Digestive Remedies in Saudi Arabia?
- Which are the leading brands in Digestive Remedies in Saudi Arabia?
- How are products distributed in Digestive Remedies in Saudi Arabia?
- How has the regulatory and operating environment for Digestive Remedies changed in Saudi Arabia?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Digestive Remedies
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
A boost to demand by targeting GLP-1 users
Saudi Pharmaceutical Industries diversifies with esomeprazole launch for symptom management
Changing diets and busy lifestyles fuel dual demand for prevention and relief
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
GLP-1 therapies set to expand opportunities for constipation and reflux solutions
Indigestion and heartburn remedies to maintain the highest sales as eating habits change
Proactive wellness and digital innovation to drive product development and access
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Jamjoom Pharma deepens manufacturing to sustain lead as rivals gain
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacist guidance secures pharmacies dominance as consumer trust remains strong
Retail e-commerce grows, with Ninja accelerating quick commerce growth as demand for speed rises
Chart 1 Retail Channels 2021-2026
Wellness and symptom relief converge in the innovation pipeline
Portfolio expansion reflects strategic product development
Innovation strategy underpins sustained commercial relevance
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Digestive Remedies
-
- Paediatric Diarrhoeal Remedies
- Paediatric Indigestion and Heartburn Remedies
- Paediatric Laxatives
- Paediatric Motion Sickness Remedies
- Diarrhoeal Remedies
- IBS Treatments
-
- Antacids
- Antiflatulents
- Digestive Enzymes
- H2 Blockers
- Proton Pump Inhibitors
- Laxatives
- Motion Sickness Remedies
Digestive Remedies
Includes remedies designed and marketed to treat gastrointestinal problems.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Digestive Remedies research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!